Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin-Etoposide/Carboplatin in Extensive SCLC
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2014
At a glance
- Drugs Irinotecan (Primary) ; Oxaliplatin (Primary) ; Carboplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2010 Planned end date changed from Jun 2010 to Jul 2011 as reported by ClinicalTrials.gov.